Prostaglandins in Cancer: A Review

References

• Honn K V, Bockman R S, Marnett L J. Prostaglandins and cancer: A review of tumor initiation through tumor metastasis. Prostaglandins 1981; 21(5)833–864
   PubMedGoogle Scholar
• Prostaglandins and Cancer: First International Conference, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R Liss, Inc., New York 1982
   Google Scholar
• Bergstrom S, Samuelsson B. Prostaglandins. Ann Rev Biochem 1965; 34: 101
   PubMed Web of Science ®Google Scholar
• Rittenhouse-Simmons S. Production of diglyceride from phosphatidylinositol in activated human platelets. J Clin Invest 1979; 63: 580
   PubMed Web of Science ®Google Scholar
• Bell R L, Kennerly D A, Stanford N, Majerus P W. Diglyceride lipase: A pathway for arachidonate release from human platelets. Proc Natl Acad Sci USA 1979; 76: 3238
   PubMed Web of Science ®Google Scholar
• Billah M M, Lapetina E G, Cuatrecasas P. Phospholipase A, activity specific for phosphatidic acid. J Biol Chem 1981; 256: 5399
   PubMed Web of Science ®Google Scholar
• Hirata F, Axelrod J. Phospholipid methylation and biological signal transmission. Science 1980; 209: 1082
   PubMed Web of Science ®Google Scholar
• Marnett L, Wlodawer P, Samuelsson B. Cooxygenation of organic substrates by the prostaglandin synthetase of sheep vesicular gland. J Biol Chem 1975; 250: 8510
   PubMed Web of Science ®Google Scholar
• Borgeat P, Hamberg M, Samuelsson B. Transformation of arachidonic acid and homo-γ-linolenic acid by rabbit polymorphonuclear leukocytes. J Biol Chem 1976; 251: 7816
   PubMed Web of Science ®Google Scholar
• Vane J R, Flower R J, Salmon J A. Inhibitors of arachidonic acid metabolism, with especial reference to the aspirin-like drugs. rostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R. Liss, Inc, New York 1981; 21
   Google Scholar
• Goodwin J S, Messner R P, Bankhurst A D, Peake G T, Saiki J H, Williams R C, Jr. Prostaglandin producing suppressor cells in Hodgkin's disease. N Engl J Med 1977; 297: 963
   PubMed Web of Science ®Google Scholar
• Bockman R. Stage-dependent reduction in T-colony formation in Hodgkin's disease. J Clin Invest 1980; 66: 523
   PubMed Web of Science ®Google Scholar
• Miller E C. Studies on the formation of protein-bound derivatives of 3, 4-benzypyrene in epidermal fraction of mouse skin. Cancer Res 1951; 11: 100–108
   PubMed Web of Science ®Google Scholar
• Heidelberger C, Weiss S M. The distribution of radioactivity in mice following administration of 3, 4-benzypyrene-5-/u14/dC and 1, 2, 5, 6-dibenzanthracene-9. 10-14C. Cancer Res 1951; 11: 885–891
   PubMed Web of Science ®Google Scholar
• Marnett L J, Reed G A, Johnson J T. Prostaglandin synthetase dependent benzo[a]pyrene oxidation: products of the oxidation and inhibition of their formation by antioxidants. Biochem Biophys Res Commun 1977; 79: 569–576
   PubMed Web of Science ®Google Scholar
• Sivarajah K, Anderson M W, Eling T E. Metabolism of benzo[a]pyrene to reactive intermediates via prostaglandin biosynthesis. Life Sci 1978; 23: 2571–2578
   PubMed Web of Science ®Google Scholar
• Sivarajah K., Lasker J M, Eling T E. Prostaglandin synthetase dependent co-oxidation of (±)-benzo[a]pyrene-7,8-dihydrodiol by human lung and other mammalian tissues. Cancer Res, in press
   Web of Science ®Google Scholar
• Zenser T V, Mattammal M B, Davis B B. Co-oxidation of benzidine by renal medullary prostaglandin cyclooxygenase. J Pharmacol Exp Ther 1980; 211: 460–464
   Web of Science ®Google Scholar
• Zenser T V, Mattammal M B, Armbrecht H J, Davis B B. Benzidine binding to nucleic acids mediated by the peroxidative activity of prostaglandin endoperoxide synthetase. Cancer Res 1980; 40: 2839–2845
   PubMed Web of Science ®Google Scholar
• Zenser T V, Mattammal M B, Davis B B. Mechanism of FANFT co-oxidation by prostaglandin endoperoxide synthetase. J Pharmacol Exp Ther 1980; 214: 312–317
   PubMed Web of Science ®Google Scholar
• Zenser T V, Mattammal M B, Brown W W., Davis B B. Cooxygenation by prostaglandin cyclooxygenase from rabbit inner medulla. Kidney Int 1979; 16: 688–694
   PubMed Web of Science ®Google Scholar
• Zenser T V, Cohen S M, Mattammal M B, Murasaki G, Davis B B. Role of prostaglandin endoperoxide synthetase in benzidine and 5-nitrofuran-induced kidney and bladder carcinogenesis. Prostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R. Liss, Inc, New York 1982
   Google Scholar
• Berenblum I, Shubik P. A new, quantitative approach to the study of the stages of chemical carcinogenesis in the mouse skin. Br J Cancer 1947; 1: 373–391
   Google Scholar
• Levine L, Hassid A. Effects of phorbol-12, 13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cells. Biochem Biophys Res Commun 1977; 79: 477–484
   PubMed Web of Science ®Google Scholar
• Brune K, KalinSchmidt H. R, Hecker E. Inflammatory, tumor initiating and promoting activities of polycyclic aromatic hydrocarbons and diterpene esters in mouse skin as compared with their prostaglandin releasing potency in vitro. Cancer Lett 1978; 4: 333, 342
   PubMed Web of Science ®Google Scholar
• Bresnick E, Meunier P, Lamden M. Epidermal prostaglandins after topical application of a tumor promoter. Cancer Lett 1979; 7: 121–125
   PubMed Web of Science ®Google Scholar
• Ashendel C L, Boutwell R K. Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol esters. Biochem Biophys Res Commun 1979; 90: 623–627
   PubMed Web of Science ®Google Scholar
• Verma A K, Rice H M, Boutwell R K. Prostaglandins and skin tumor promotion: Inhibition of tumor promoter-induced ornithine decarboxylase activity by inhibitors of prostaglandin synthesis. Biochem Biophys Res Commun 1977; 79: 1160–1166
   PubMed Web of Science ®Google Scholar
• Verma A K, Ashendel C L, Boutwell R K. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal or-nithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res 1980; 40: 308–315
   PubMed Web of Science ®Google Scholar
• Furstenberger G, Marks F. Indomethacin inhibition of cell proliferation induced by the phorbol ester TPA is reversed by prostaglandin E2 in mouse epidermis in vivo. Biochem Biophys Res Commun 1978; 84: 1103–1111
   PubMed Web of Science ®Google Scholar
• Fisher S M, Gleason G L, Mills G D, Slaga T L. Indomethacin enhancement of TPA tumor promotion in mice. Cancer Lett 1980; 10: 343
   PubMed Web of Science ®Google Scholar
• Smith J W, Steiner A L, Parker C W. Human lymphocyte metabolism: Effects of cyclic and non cyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest 1971; 50: 442–448
   PubMed Web of Science ®Google Scholar
• Santoro M G, Philpott G W, Jaffe B M. Inhibition of tumor growth in vivo and in vitro by prostaglandin E. Nature (London) 1976; 263: 777–779
   PubMed Web of Science ®Google Scholar
• Thomas D R, Philpott G W, Jaffe B M. The relationship between concentration of prostaglandin E and rates of cell replication. Exp Cell Res 1974; 84: 40–46
   PubMed Web of Science ®Google Scholar
• Claesson H-E, Lindgren J A, Hammarstrom S. Endogenous prostaglandin E2 production inhibits proliferation of polyoma virus-transformed 3T3 cells: correlation with cellular levels of cyclic AMP. Adv Prost Thromb Res 1980; 6: 541–545
   PubMedGoogle Scholar
• Bockman R S, Rothschild M. Prostaglandin E inhibition of T-lymphocyte colony formation: a possible mechanism on monocyte modulation of clonal expansion. J Clin Invest 1979; 64: 812
   PubMed Web of Science ®Google Scholar
• Hammarstrom S. Endogenous prostaglandin production and cell replication in vitro. Prostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R. Liss Inc, New York 1982; 415
   Google Scholar
• De Asua L J, Clingan D, Rudland P S. Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2α. Proc Natl Acad Sci USA 1975; 72: 2724–P2728
   PubMed Web of Science ®Google Scholar
• Karmali R A, Horrobin D F, Menezes J, Patel P. The relationship between concentrations of prostaglandin A1, E1, E2 and F2α and rates of cell proliferation. Pharmacol Res Commun 1979; 11: 69–75
   PubMedGoogle Scholar
• Trevisani A, Ferretti E, Capuzzo A, Tomasi V. Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumor growth by non-steroidal anti-inflammatory drugs. Br J Cancer 1980; 41: 341–347
   PubMed Web of Science ®Google Scholar
• Stobo J D, Kennedy M S, Goldyne M E. Prostaglandin E modulation of the mitogenic response of human T-cells. J Clin Invest 1979; 64: 1188–1195
   PubMed Web of Science ®Google Scholar
• De Asua L J, Otto A M, Ulrich M O, Martin-Perez J, Thomas G. The regulation of DNA replication in animal cells by prostaglandin F2α. Prostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R Liss Inc, New York 1982; 309
   Google Scholar
• Bockman R, Bellin A, Repo M A, Hickok N, Kameya T. In vivo and in vitro biologic of two human cell lines derived from anaplastic lung cancers. Cancer Res 1983; 43: 4511–4516
   PubMed Web of Science ®Google Scholar
• Kurland J I, Bockman R S, Broxmeyer H E, Moore M AS. Limitation of excessive myelopoiesis by the extrinsic modulation of macrophage derived prostaglandin E. Science 1978; 199: 552–555
   PubMed Web of Science ®Google Scholar
• Kurland J, Broxmeyer H, Bockman R S, Pelus L, Moore M AS. Role for monocyte-macrophage derived colony stimulating factor and prostaglandin E in positive and negative feedback control of myeloid stem cell proliferation. Blood 1978; 52: 388–407
   PubMed Web of Science ®Google Scholar
• Pelus L M, Broxmeyer H E, Kurland J I, Moore M AS. Regulation of macrophage and granulocyte proliferation: specificities of prostaglandin E and lactoferrin. J Exp Med 1979; 150: 277–292
   PubMed Web of Science ®Google Scholar
• Metcalf D, Foster R. Behavior on transfer of serum stimulated bone marrow colonies. Proc Soc Exp Biol Med 1967; 126: 758–762
   Web of Science ®Google Scholar
• Stanley E R, Metcalf D. Purification and properties of human urinary colony stimulating factor (CSF). Cell Differentiation, R Harris, D Vizza. Copenhagen, Munksgaard 1972; 272
   Google Scholar
• Zeevi A, Goldman I, Rosenszajn L A. Stimulation and inhibition of human T-lymphocyte colony cell proliferation by hematopoietic cell factors. Cell Immunol 1977; 28: 235
   PubMed Web of Science ®Google Scholar
• Kurland J I, Pelus L, Ralph P, Bockman R S, Moore M AS. Induction of prostaglandin E synthesis in normal and neoplastic macrophages: A new role for colony stimulating factor(s). Proc Natl Acad Sci USA 1979; 76(5)2326–2330
   PubMed Web of Science ®Google Scholar
• Koeffler H P, Golde D W. Humoral modulation of human acute myelogenous leukemia cell growth in vitro. Cancer Res 1980; 40: 1858–1862
   PubMed Web of Science ®Google Scholar
• Aglietta M, Piacibello W, Gavosto F. Insensitivity of chronic myeloid leukemia cells to inhibition of growth by prostaglandin E. Cancer Res 1980; 40: 2507–2511
   PubMed Web of Science ®Google Scholar
• Pelus L M, Broxmeyer H E, Clarkson B D, Moore M AS. Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E. Cancer Res 1980; 40: 2512–2515
   PubMed Web of Science ®Google Scholar
• Ichikawa Y. Differentiation of a cell line in myeloid leukemia. J Cell Physiol 1969; 74: 233–234
   Google Scholar
• Snyder D S. Regulation of murine macrophage la expression by prostaglandins. Fed Proc 1982; 3188
   Google Scholar
• Pelus L. Antigenic and humoral control of normal and leukemic human myelopoiesis. Prostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R Liss Inc, New York 1982; 399
   Google Scholar
• Dukes P P. Potentiation of erythropoietin effects in marrow cell cultures by prostaglandin E, or cyclic 3',5'-AMP. Blood 1971; 38: 822
   Web of Science ®Google Scholar
• Schooley J C, Mahlmann L J. Stimulation of erythropoiesis in plethoric mice by prostaglandins and its inhibition by anti erythropoietin. Proc Soc Exp Biol Med 1971; 138: 523–524
   PubMed Web of Science ®Google Scholar
• Santoro M G, Benedetto A, Jaffe B M. Prostaglandin A1 induce differentiation in Friend erythroleukemia cells. Prostaglandins 1979; 17: 719–727
   PubMedGoogle Scholar
• Santoro M, Benedetto G. A, Jaffe B M. Effect of endogenous and exogenous PGE on Friend erythroleukemia cell growth and differentiation. Br J Cancer 1979; 39: 259
   PubMed Web of Science ®Google Scholar
• Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976; 16: 207
   PubMedGoogle Scholar
• Polverini P, Cotran J. RS., Gimbrone J MA, Unanue E R. Activated macrophages induce vascular proliferation. Nature (London) 1977; 269: 804
   PubMed Web of Science ®Google Scholar
• Sidky Y A, Auerbach R. Lymphocyte-induced angiogenesis (LIA): A quantitative and sensitive assay of graft-vs-host reaction. J Exp Med 1975; 141: 1084
   PubMed Web of Science ®Google Scholar
• Auerbach R. Angiogenesis-inducing factors: A review. Lymphokines, E Pick. Academic Press, New York, Vol 4, in press
   Google Scholar
• Ben Ezra D. Neovasculogenesis. Triggering factors and possible mechanisms. Surv Ophthalmol 1978; 24: 165, 24:455, 1978
   Google Scholar
• Cooper C A, Bergamini M VW, Leopold I H. Used of flurbiprofen to inhibit corneal neovascularization. Arch Ophthalmol 1980; 98: 1102
   PubMed Web of Science ®Google Scholar
• Form D M, Sidky Y A, Kubai L, Auerbach R. PGE2-induced angiogenesis. Prostaglandins and Cancer, T J Powles, R S Bock-Man, K V Honn, P Ramwell. Alan R Liss Inc, New York 1982; 685
   Google Scholar
• Bockman R. Prostaglandins. The Lymphokines, J Hadden, W Stewart. Humana Press, Inc, Clifton, NJ 1981; 367
   Google Scholar
• Parker C W. Arachidonate metabolites and immunity. Prostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R Liss Inc, New York 1982; 595
   Google Scholar
• Goodwin J, Husby G, Williams R C, Jr. Prostaglandin E and cancer growth. Cancer Immunol Immunother 1980; 8: 3
   Web of Science ®Google Scholar
• Bray M S, Gordon D, Morley J. Role of prostaglandins in reactions of cellular immunity. Br J Pharmcol 1974; 52: 453
   Google Scholar
• Rappaport R S, Dodge G R. Prostaglandin E inhibits the production of human interleukin 2. J Exp Med 1982; 155: 943
   PubMed Web of Science ®Google Scholar
• Yoneda T, Mundy G R. Prostaglandins are necessary for osteoclast-activating factor production by activated peripheral blood leukocytes. J Exp Med 1979; 150: 279
   Google Scholar
• Wahl L M, Olsen C E, Sandberg A L, Mergenhagen S E. Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci (USA) 1977; 74: 4955
   PubMed Web of Science ®Google Scholar
• Bockman R S, Straus D, Dimich A. Prostaglandin-dependent lymphokine secretion is followed by prostaglandin-mediated bone resorption in malignant lymphoma. Calcif Tiss Int 1981; 33: 291a
   Web of Science ®Google Scholar
• Alexander P. Prostaglandins in relation to tumor-host interaction. Prostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R Liss Inc, New York 1982; 581
   Google Scholar
• Gasic G J, Gasic T B, Galanti N, Johnson T, Murphy S. Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer 1973; 11: 704–718
   PubMed Web of Science ®Google Scholar
• Gasic G J, Koch P AG, Hsu B, Gasic T B, Niewiarowski S. Thrombogenic activity of mouse and human tumors: Effects on platelets, coagulation, and fibrinolysis, and possible significance for metatasis. Z Krebsforsch 1976; 86: 263–277
   Google Scholar
• Malignancy and the Hemostatic System, M B Donati, J F Davidson, S Garattini. Raven Press, New York 1981
   Google Scholar
• Elias E G, Sepulveda F, Mink I B. Increasing the efficiency of cancer chemotherapy with heparin: “Clinical Study.”. J Surg Oncol 1973; 5: 189–193
   PubMedGoogle Scholar
• Lione A, Bosmann H B. The inhibitory effect of heparin and warfarin treatments on the intravascular survival of B 16 melanoma cells in syngeneic C57 mice. Cell Biol Int Rep 1978; 2: 81–86
   PubMedGoogle Scholar
• Giraldi T, Sava G, Kopitar M, Brzin Turk J. V. Neutral proteinase inhibitors and antimetastatic effects in mice. Eur J Cancer 1980; 16: 449–454
   PubMed Web of Science ®Google Scholar
• Honn K V, Cicone B, Skoff A, Romine M, Gossett D, Thompson K, Hodge D. Thromboxane synthetase inhibitors and prostacyclin can control tumor cell metastasis. J Cell Biol 1980; 87: 64
   Google Scholar
• Honn K V. Prostacyclin/thromboxane ratios in tumor growth and metastasis thromboxane. Prostaglandins and Cancer, T J Powles, R S Bockman, K V Honn, P Ramwell. Alan R Liss Inc, New York 1982; 733
   Google Scholar
• Sloane B, Dunn J, Honn K V. Lysosomal cathepsin B: A correlation with metastatic potential. Science 1981; 212: 1151
   PubMed Web of Science ®Google Scholar